2025 fourth_quarter Filing
Q4Income
$50K
Filed
January 20, 2026
Lobbying Activities
Medicare/MedicaidView all
Access and pricing issues for plasma derived products; Orphan Drug Act and therapies for rare diseases. H.R. 1, One Big Beautiful Bill Act implementation, issues related to biopharmaceutical issues. Prescription drug pricing issues, particularly related to MFN. Medicare Part B provisions relating to home infusion of IVIG.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Health IssuesView all
Matters related to access of plasma derived products, FDA drug approval and monitoring agency changes. Matters affecting plasma donation and potential plasma shortages. Pharmacy Benefit Manager reform.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (7)
ms MELINDA M MAXFIELD
LAURA M SIMMONS
Advisor, Office of Legislative Affairs, Dept of Homeland Security
CHRISTOPHER E. WILCOX
LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
JEANNE HAGGERTY
Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member